Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynamin-3 (DNM3) is a member of the dynamin superfamily of large GTPases involved in membrane remodeling, fission, and vesicle formation[1][5][6]. DNM3 possesses a N-terminal GTPase domain, pleckstrin homology (PH) domain for membrane interaction, and a proline/arginine-rich domain (PRD) that serves as a hub for binding SH3 domain-containing proteins[1][2][6]. DNM3 is critical for clathrin-mediated endocytosis, functioning in the scission of vesicles from the plasma membrane and regulating receptor trafficking, especially in neurons where it mediates postsynaptic receptor recycling through interaction with adaptor proteins such as Homer[3]. DNM3 also plays an essential role in megakaryocyte development and platelet biogenesis, influencing progenitor amplification, cytoplasmic enlargement, and demarcation membrane system (DMS) formation[1]. Disruption or knockdown of DNM3 significantly impairs megakaryocyte maturation and can reduce platelet production[1]. While DNM3 is implicated in neurobiology, metabolism, and hematopoiesis, it is not currently the direct target of any approved therapeutic agents and remains primarily a subject of basic and translational research.
Inhibition of dynamin GTPase activity (experimental compounds only), disruption of vesicle fission and endocytosis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynamin-3 (DNM3).